AI-generated summary
The authors studied 60 patients with diabetic peripheral neuropathy who were matched and randomized to laser therapy or sham therapy for one month. They report that laser therapy was associated with greater improvement in pain and neuropathy scores than sham at 2 and 4 weeks, but they found no statistically significant difference between 2 and 4 week results. The authors call for further studies.
- Participants
- 60
- Who or what was studied
- Patients with diabetic peripheral neuropathy
- Wavelengths
- 78 nm
- Limits stated in the abstract
- The abstract reports the study as an unclear trial with a wavelength value of 78 nm that appears to be a reporting error, and it calls for further studies to confirm reproducible results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 2.5 j/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Low-level laser therapy, Neuropathy, Sham, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.